Correlation Between Milestone Pharmaceuticals and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Mink Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Mink Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Mink Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Milestone and Mink is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Mink Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 86.74 times less return on investment than Mink Therapeutics. But when comparing it to its historical volatility, Milestone Pharmaceuticals is 5.12 times less risky than Mink Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Mink Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 780.00 in Mink Therapeutics on November 9, 2024 and sell it today you would earn a total of 330.00 from holding Mink Therapeutics or generate 42.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Mink Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Mink Therapeutics |
Milestone Pharmaceuticals and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Mink Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |